DOI QR코드

DOI QR Code

Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1'S-1'-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4

  • Phuah, Neoh Hun (Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya) ;
  • Azmi, Mohamad Nurul (Centre for Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya) ;
  • Awang, Khalijah (Centre for Natural Product Research and Drug Discovery (CENAR), Department of Chemistry, Faculty of Science, University of Malaya) ;
  • Nagoor, Noor Hasima (Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University of Malaya)
  • Received : 2016.11.29
  • Accepted : 2017.04.05
  • Published : 2017.04.30

Abstract

MicroRNAs (miRNAs) are short non-coding RNAs that regulate genes posttranscriptionally. Past studies have reported that miR-210 is up-regulated in many cancers including cervical cancer, and plays a pleiotropic role in carcinogenesis. However, its role in regulating response towards anti-cancer agents has not been fully elucidated. We have previously reported that the natural compound 1'S-1'-acetoxychavicol acetate (ACA) is able to induce cytotoxicity in various cancer cells including cervical cancer cells. Hence, this study aims to investigate the mechanistic role of miR-210 in regulating response towards ACA in cervical cancer cells. In the present study, we found that ACA down-regulated miR-210 expression in cervical cancer cells, and suppression of miR-210 expression enhanced sensitivity towards ACA by inhibiting cell proliferation and promoting apoptosis. Western blot analysis showed increased expression of mothers against decapentaplegic homolog 4 (SMAD4), which was predicted as a target of miR-210 by target prediction programs, following treatment with ACA. Luciferase reporter assay confirmed that miR-210 binds to sequences in 3'UTR of SMAD4. Furthermore, decreased in SMAD4 protein expression was observed when miR-210 was overexpressed. Conversely, SMAD4 protein expression increased when miR-210 expression was suppressed. Lastly, we demonstrated that overexpression of SMAD4 augmented the anti-proliferative and apoptosis-inducing effects of ACA. Taken together, our results demonstrated that down-regulation of miR-210 conferred sensitivity towards ACA in cervical cancer cells by targeting SMAD4. These findings suggest that combination of miRNAs and natural compounds could provide new strategies in treating cervical cancer.

Keywords

References

  1. Awang, K., Azmi, M.N., Aun, L.I., Aziz, A.N., Ibrahim, H., and Nagoor, N.H. (2010). The apoptotic effect of 1's-1'-acetoxychavicol acetate from Alpinia conchigera on human cancer cells. Molecules 15, 8048-8059. https://doi.org/10.3390/molecules15118048
  2. Baez, A., Cantor, A., Fonseca, S., Marcos-Martinez, M., Mathews, L.A., Muro-Cacho, C.A., and Munoz-Antonia, T. (2005). Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma. Clin. Cancer Res. 11, 3191-3197. https://doi.org/10.1158/1078-0432.CCR-04-1299
  3. Baldus, S.E., Schwarz, E., Lohrey, C., Zapatka, M., Landsberg, S., Hahn, S.A., Schmidt, D., Dienes, H.P., Schmiegel, W.H., and Schwarte-Waldhoff, I. (2005). Smad4 deficiency in cervical carcinoma cells. Oncogene 24, 810-819. https://doi.org/10.1038/sj.onc.1208235
  4. Camps, C., Buffa, F.M., Colella, S., Moore, J., Sotiriou, C., Sheldon, H., Harris, A.L., Gleadle, J.M., and Ragoussis, J. (2008). hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14, 1340-1348. https://doi.org/10.1158/1078-0432.CCR-07-1755
  5. Cheng, H., Fertig, E.J., Ozawa, H., Hatakeyama, H., Howard, J.D., Perez, J., Considine, M., Thakar, M., Ranaweera, R., Krigsfeld, G., et al. (2015). Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma. Cancer Biol. Ther. 16, 1252-1258. https://doi.org/10.1080/15384047.2015.1056418
  6. Crafton, S.M., and Salani, R. (2016). Beyond chemotherapy: an overview and review of targeted therapy in cervical cancer. Clin. Ther. 38, 449-458. https://doi.org/10.1016/j.clinthera.2016.02.007
  7. Cragg, G.M., and Newman, D.J. (2005). Plants as a source of anticancer agents. J. Ethnopharmacol. 100, 72-79. https://doi.org/10.1016/j.jep.2005.05.011
  8. Dang, K., and Myers, K.A. (2015). The role of hypoxia-induced miR- 210 in cancer progression. Int. J. Mol. Sci. 16, 6353-6372. https://doi.org/10.3390/ijms16036353
  9. Gottesman, M.M. (2002). Mechanisms of cancer drug resistance. Annu. Rev. Med. 53, 615-627. https://doi.org/10.1146/annurev.med.53.082901.103929
  10. Greither, T., Grochola, L.F., Udelnow, A., Lautenschlager, C., Wurl, P., and Taubert, H. (2010). Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer 126, 73-80. https://doi.org/10.1002/ijc.24687
  11. Hernanda, P.Y., Chen, K., Das, A.M., Sideras, K., Wang, W., Li, J., Cao, W., Bots, S.J., Kodach, L.L., de Man, R.A., et al. (2015). SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma. Oncogene 34, 5055-5068. https://doi.org/10.1038/onc.2014.425
  12. Ho, C.S., Yap, S.H., Phuah, N.H., In, L.L., and Hasima, N. (2014). MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells. Lung Cancer 83, 154-162. https://doi.org/10.1016/j.lungcan.2013.11.024
  13. Jung, E.J., Santarpia, L., Kim, J., Esteva, F.J., Moretti, E., Buzdar, A.U., Di Leo, A., Le, X.F., Bast, R.C., Jr., Park, S.T., et al. (2012). Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer 118, 2603-2614. https://doi.org/10.1002/cncr.26565
  14. Kim, Y., Kim, H., Park, D., and Jeoung, D. (2015). miR-335 targets SIAH2 and confers sensitivity to anti-cancer drugs by increasing the expression of HDAC3. Mol. Cells 38, 562-572. https://doi.org/10.14348/molcells.2015.0051
  15. Klein-Scory, S., Zapatka, M., Eilert-Micus, C., Hoppe, S., Schwarz, E., Schmiegel, W., Hahn, S.A., and Schwarte-Waldhoff, I. (2007). Highlevel inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition. BMC Cancer 7, 209. https://doi.org/10.1186/1471-2407-7-209
  16. Kloth, J.N., Kenter, G.G., Spijker, H.S., Uljee, S., Corver, W.E., Jordanova, E.S., Fleuren, G.J., and Gorter, A. (2008). Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival. Mod. Pathol. 21, 866-875. https://doi.org/10.1038/modpathol.2008.62
  17. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., and Tuschl, T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858. https://doi.org/10.1126/science.1064921
  18. Lee, S., Cho, Y.S., Shim, C., Kim, J., Choi, J., Oh, S., Kim, J., Zhang, W., and Lee, J. (2001). Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervical carcinoma cell line. Int. J. Cancer 94, 500-507. https://doi.org/10.1002/ijc.1494
  19. Liang, Z., Li, S., Xu, X., Xu, X., Wang, X., Wu, J., Zhu, Y., Hu, Z., Lin, Y., Mao, Y., et al. (2015). MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1. Mol. Cells 38, 130-137. https://doi.org/10.14348/molcells.2015.2146
  20. Liu, N., Yu, C., Shi, Y., Jiang, J., and Liu, Y. (2015). SMAD4 expression in breast ductal carcinoma correlates with prognosis. Oncol. Lett. 10, 1709-1715. https://doi.org/10.3892/ol.2015.3442
  21. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25, 402-408. https://doi.org/10.1006/meth.2001.1262
  22. Lou, M., Jia, Y., Duan, Z., Wu, J., Luo, M., and Wang, Y. (2016). Correlation between human papillomavirus and microRNA-210 in hypoxia-associated human cervical cancer. Int. J. Clin. Exp. Pathol. 9, 1148-1157.
  23. Martinez, I., Gardiner, A.S., Board, K.F., Monzon, F.A., Edwards, R.P., and Khan, S.A. (2008). Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27, 2575-2582. https://doi.org/10.1038/sj.onc.1210919
  24. Millimouno, F.M., Dong, J., Yang, L., Li, J., and Li, X. (2014). Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature. Cancer Prev. Res. 7, 1081-1107. https://doi.org/10.1158/1940-6207.CAPR-14-0136
  25. Miyaki, M., Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T., et al. (1999). Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18, 3098-3103. https://doi.org/10.1038/sj.onc.1202642
  26. Monk, B.J., Sill, M.W., McMeekin, D.S., Cohn, D.E., Ramondetta, L.M., Boardman, C.H., Benda, J., and Cella, D. (2009). Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J. Clin. Oncol. 27, 4649-4655. https://doi.org/10.1200/JCO.2009.21.8909
  27. Othman, N., In, L.L., Harikrishna, J.A., and Hasima, N. (2013). Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells. PLoS One 8, e81735. https://doi.org/10.1371/journal.pone.0081735
  28. Papageorgis, P., Cheng, K., Ozturk, S., Gong, Y., Lambert, A.W., Abdolmaleky, H.M., Zhou, J.R., and Thiagalingam, S. (2011). Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Res. 71, 998-1008. https://doi.org/10.1158/0008-5472.CAN-09-3269
  29. Phuah, N.H., and Nagoor, N.H. (2014). Regulation of microRNAs by natural agents: new strategies in cancer therapies. Biomed. Res. Int. 2014, 804510.
  30. Phuah, N.H., In, L.L., Azmi, M.N., Ibrahim, H., Awang, K., and Nagoor, N.H. (2013). Alterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1'S-1'- acetoxychavicol acetate and cisplatin. Reprod. Sci. 20, 567-578. https://doi.org/10.1177/1933719112459220
  31. Qin, Q., Furong, W., and Baosheng, L. (2014). Multiple functions of hypoxia-regulated miR-210 in cancer. J. Exp. Clin. Cancer Res. 33, 50. https://doi.org/10.1186/1756-9966-33-50
  32. Rao, Q., Shen, Q., Zhou, H., Peng, Y., Li, J., and Lin, Z. (2012). Aberrant microRNA expression in human cervical carcinomas. Med. Oncol. 29, 1242-1248. https://doi.org/10.1007/s12032-011-9830-2
  33. Tang, X., Chen, L., Yan, X., Li, Y., Xiong, Y., and Zhou, X. (2015). Overexpression of miR-210 is associated with poor prognosis of acute myeloid leukemia. Med. Sci. Monit. 21, 3427-3433. https://doi.org/10.12659/MSM.894812
  34. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., and Jemal, A. (2015). Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87-108. https://doi.org/10.3322/caac.21262
  35. Wu, S., Huang, S., Ding, J., Zhao, Y., Liang, L., Liu, T., Zhan, R., and He, X. (2010). Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene 29, 2302-2308. https://doi.org/10.1038/onc.2010.34
  36. Yang, W., Sun, T., Cao, J., Liu, F., Tian, Y., and Zhu, W. (2012). Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp. Cell Res. 318, 944-954. https://doi.org/10.1016/j.yexcr.2012.02.010
  37. Yang, W., Wei, J., Sun, T., and Liu, F. (2013). Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice. Radiat. Oncol. 8, 102. https://doi.org/10.1186/1748-717X-8-102
  38. Yu, S.L., Lee, D.C., Son, J.W., Park, C.G., Lee, H.Y., and Kang, J. (2013). Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells. Oncol. Rep. 30, 1293-1300. https://doi.org/10.3892/or.2013.2578
  39. Zhang, B., Zhang, B., Chen, X., Bae, S., Singh, K., Washington, M.K., and Datta, P.K. (2014). Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway. Br. J. Cancer 110, 946-957. https://doi.org/10.1038/bjc.2013.789
  40. Zhang, B., Leng, C., Wu, C., Zhang, Z., Dou, L., Luo, X., Zhang, B., and Chen, X. (2016). Smad4 sensitizes colorectal cancer to 5- fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade. Oncol. Rep. 35, 1807-1815. https://doi.org/10.3892/or.2015.4479

Cited by

  1. Onset and Progression of Human Osteoarthritis—Can Growth Factors, Inflammatory Cytokines, or Differential miRNA Expression Concomitantly Induce Proliferation, ECM Degradation, and Inflammation in Articular Cartilage? vol.19, pp.8, 2018, https://doi.org/10.3390/ijms19082282
  2. MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness vol.10, pp.1664-8021, 2019, https://doi.org/10.3389/fgene.2019.00125
  3. miR-3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression vol.17, pp.5, 2017, https://doi.org/10.3892/mmr.2018.8697
  4. Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health vol.9, pp.3, 2017, https://doi.org/10.2174/2211536608666191026115045
  5. Pharmacological Effects of 1′-Acetoxychavicol Acetate, a Major Constituent in the Rhizomes of Alpinia galanga and Alpinia conchigera vol.23, pp.5, 2017, https://doi.org/10.1089/jmf.2019.4490
  6. Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review vol.13, pp.1, 2017, https://doi.org/10.3390/nu13010154
  7. Effects of miR‑210‑3p on the erythroid differentiation of K562 cells under hypoxia vol.24, pp.2, 2017, https://doi.org/10.3892/mmr.2021.12202
  8. The role of vulpinic acid as a natural compound in the regulation of breast cancer-associated miRNAs vol.54, pp.1, 2017, https://doi.org/10.1186/s40659-021-00360-4